Moreover, Pseudokinase TRIB3 promotes multiple myeloma progression by stabilizing SSRP1 through USP10-mediated deubiquitination, thereby enhancing oncogenic signaling and tumor growth70. Here, SSRP1 is linked to neoplasm.